Evidence map›Paper›PMID 30007283›Full record

ReviewEndocrine reviews2018

The Biology of Normal Zona Glomerulosa and Aldosterone-Producing Adenoma: Pathological Implications.

Teresa M Seccia, Brasilina Caroccia, Elise P Gomez-Sanchez, Celso E Gomez-Sanchez, Gian Paolo Rossi

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Endocrine reviews, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04185857 (Effects of Mineralocorticoid and AT-1 Receptor Antagonism on the Aldosterone-Renin Ratio), which is not on this map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04185857 completednot on this map

Effects of Mineralocorticoid and AT-1 Receptor Antagonism on the Aldosterone-Renin Ratio (ARR) In Primary Aldosteronism Patients (EMIRA Study): Rationale and Design

TypeobservationalSponsorUniversity Hospital PadovaRan2018 to 2019Enrolled50ConditionsPrimary Aldosteronism Due to Aldosterone Producing AdenomaArmscanrenone 50-100 mg orally once a day, olmesartan 10-20 mg orally once a day
3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 98 citations in OpenAlex.

  1. Article
  2. Article
  3. Low 5HTJournal of neurochemistry · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Water and Electrolyte Content in Salt-Dependent HYpertension in the SKIn (WHYSKI): Effect of Surgical Cure of Primary Aldosteronism.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2024
    Article
  13. Review
  14. Article
  15. 18-Oxocortisol: A journey.The Journal of steroid biochemistry and molecular biology · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. A Novel Somatic Mutation ofFrontiers in endocrinology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Teresa M SecciaDepartment of Medicine-DIMED, University of Padua, Padua PD, Italy.
Brasilina CarocciaDepartment of Medicine-DIMED, University of Padua, Padua PD, Italy.
Elise P Gomez-SanchezDepartment of Pharmacology and Toxicology, G.V. (Sonny) Montgomery VA Medical Center, Jackson, Mississippi.
Celso E Gomez-SanchezDivision of Endocrinology, G.V. (Sonny) Montgomery VA Medical Center, Jackson, Mississippi.
Gian Paolo RossiDepartment of Medicine-DIMED, University of Padua, Padua PD, Italy.
University of Padua · ITG.V. (Sonny) Montgomery VA Medical Center · US

Funding

ROLE OF MINERALOCORTICOIDS IN LOW-RENIN HYPERTENSIONR01HL027255 · NHLBI · UNIVERSITY OF SOUTH FLORIDA · PI GOMEZ-SANCHEZ, CELSO ENRIQUE · 1985 to 2017
$3.9M
NHLBI NIH HHS R01 HL027255
6 · The paper itself

Abstract

The identification of several germline and somatic ion channel mutations in aldosterone-producing adenomas (APAs) and detection of cell clusters that can be responsible for excess aldosterone production, as well as the isolation of autoantibodies activating the angiotensin II type 1 receptor, have rapidly advanced the understanding of the biology of primary aldosteronism (PA), particularly that of APA. Hence, the main purpose of this review is to discuss how discoveries of the last decade could affect histopathology analysis and clinical practice. The structural remodeling through development and aging of the human adrenal cortex, particularly of the zona glomerulosa, and the complex regulation of aldosterone, with emphasis on the concepts of zonation and channelopathies, will be addressed. Finally, the diagnostic workup for PA and its subtyping to optimize treatment are reviewed.

Indexed as

Adrenal Cortex NeoplasmsAdrenocortical AdenomaAgingHyperaldosteronismZona GlomerulosaAldosteroneHumansAldosterone

Identifiers

PMID30007283
PMCPMC6236434
OpenAlexW2822595200

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.